ABBV-181

ABBV-181 is an anti-PD1 monoclonal antibody that is being developed for combinations with other AbbVie molecules for solid tumors and hematologic malignancies.

Type of Molecule

Biologic

Target

anti-PD1

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Solid Tumors n/a
Phase 1